Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

NCT00939770

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 28 locations
View Trial Details
Completed

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

NCT01742286

Conditions
ALK-activated Tumors, Granuloma, Granuloma, Plasma Cell, +26 more
Locations
  • Dana Farber Cancer Institute Dept of Onc Boston, Massachusetts, United States
  • Memorial Sloan Kettering SC - 7 New York, United States
  • Cincinnati Children s Hospital Medical Center Dept of Oncology Cincinnati, Ohio, United States
  • St Jude s Childrens Research Hospital Dept of Oncology Memphis, Tennessee, United States
View all 23 locations
View Trial Details
Completed

MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

NCT02764281

Conditions
Extranodal NK-T-Cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations
  • Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Eye Ear Nose and Throat Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Xinhua Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Completed

MAgnetic Resonance Imaging in COeliac Disease

NCT02551289

Conditions
Celiac Disease, Celiac Sprue, Coeliac Disease, +18 more
Locations
  • NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust and the University of Nottingham Nottingham, United Kingdom
View Trial Details
Completed

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817

Conditions
Bone Marrow Transplant Failure, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

NCT00014209

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +12 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Moncton Hospital Moncton, New Brunswick, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
View all 13 locations
View Trial Details
Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University Montreal, Quebec, Canada
View Trial Details

Related conditions